日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction to: Local cranial radiation combined with third-generation tyrosine kinase inhibitors improve leptomeningeal metastasis disease-free survival in patients with EGFR-mutated non-small cell lung cancer and brain metastasis

更正:局部颅脑放射治疗联合第三代酪氨酸激酶抑制剂可改善EGFR突变型非小细胞肺癌脑转移患者的软脑膜转移无病生存期

Wang, Qian; Wang, Hui; Hong, Weiping; Bashir, Shoaib; Hua, Xiaoyu; Yang, Yanying; Zhen, Junjie; Li, Juan; Lai, Mingyao; Cai, Linbo

EGFR A859S alteration may predict a better response to third-generation EGFR-TKI treatment in advanced NSCLC

EGFR A859S 突变可能预示晚期非小细胞肺癌患者对第三代 EGFR-TKI 治疗的疗效更佳。

Hong, Weiping; Fu, Wenfan; Ma, Ya; Wang, Chenxuan; Xu, Yang; Yin, Jiani; Pang, Jiaohui; Ou, Qiuxiang; Bao, Hua; Gu, Jincui; Li, Baoxiu

Negative Regulation of Cell Adhesion as a Driver of Brain Metastasis in NSCLC Patients with EGFR Amplification

EGFR扩增的非小细胞肺癌患者脑转移的驱动因素:细胞黏附的负调控

Yang, Hainan; Hu, Congli; Zhou, Yu; Tong, Taoyuan; Qi, Luyao; Yuan, Weifang; Shan, Changguo; Hong, Weiping; Wen, Lei; Zhou, Caicun; Lei, Ming

Corrigendum to "TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastases" [Heliyon Volume 10, Issue 16, August 2024, Article e36532]

对“TP53 和 EGFR 扩增是诊断为非小细胞肺癌伴脑转移患者的总生存期的负面预测因子”的更正 [Heliyon 第 10 卷,第 16 期,2024 年 8 月,文章 e36532]

Lin, Tao; Tang, Xusheng; Yang, Wanli; Yang, Hainan; Zhou, Zhaoming; Chen, Zhijie; Zeng, Yongqin; Hong, Weiping; Ye, Minting; Cai, Linbo; Liu, Da; Li, Minying; Wen, Lei

Local cranial radiation combined with third-generation tyrosine kinase inhibitors improve leptomeningeal metastasis disease-free survival in patients with EGFR-mutated non-small cell lung cancer and brain metastasis

局部颅脑放射治疗联合第三代酪氨酸激酶抑制剂可改善EGFR突变型非小细胞肺癌脑转移患者的软脑膜转移无病生存期。

Wang, Qian; Wang, Hui; Hong, Weiping; Bashir, Shoaib; Hua, Xiaoyu; Yang, Yanying; Zhen, Junjie; Li, Juan; Lai, Mingyao; Cai, Linbo

Development and validation of a predictive nomogram for leptomeningeal metastasis risk in NSCLC brain metastases: role of tumor location, driver mutations, and stereotactic radiosurgery

建立和验证用于预测非小细胞肺癌脑转移中软脑膜转移风险的列线图:肿瘤位置、驱动基因突变和立体定向放射外科的作用

Bashir, Shoaib; Jian, Song; Hong, Weiping; Wang, Hui; Lai, Mingyao; Lin, Hanbo; Liang, Qianwen; Xu, Meng; Cai, Linbo

Cisplatin resistance-related transcriptome and methylome integration identifies PCDHB4 as a novel prognostic biomarker in small cell lung cancer

顺铂耐药相关转录组和甲基化组整合分析表明,PCDHB4 是小细胞肺癌的一种新型预后生物标志物

Qizhi Zhu ,Meng Fu ,Jian Qi ,Ziming Xu ,Yongguang Wang ,Zhipeng Wang ,Dan Wang ,Jiajia Liu ,Ruiping Du ,Xin Wei ,Hongzhi Wang ,Jinfu Nie ,Bo Hong ,Weiping Xu

PMS2 amplification contributes brain metastasis from lung cancer.

PMS2 扩增是肺癌脑转移的促成因素

Chen Jianing, Hu Congli, Yang Hainan, Wang Li, Chu Xiangling, Yu Xin, Zhang Shiji, Li Xuefei, Zhao Chao, Cheng Lei, Hong Weiping, Liu Da, Wen Lei, Su Chunxia

TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastases

TP53 和 EGFR 扩增是诊断为脑转移性非小细胞肺癌患者总生存期的负面预测因子。

Lin, Tao; Tang, Xusheng; Yang, Wanli; Yang, Hainan; Zhou, Zhaoming; Chen, Zhijie; Zeng, Yongqin; Hong, Weiping; Ye, Minting; Cai, Linbo; Liu, Da; Li, Minying; Wen, Lei

Mutational signatures of synchronous and metachronous brain metastases from lung adenocarcinoma

肺腺癌同步性和异时性脑转移的突变特征

Chen, Jianing; Yang, Hainan; Zhao, Chao; Lin, Tao; Liu, Da; Hong, Weiping; Shan, Changguo; Zhou, Cheng; Bao, Ling; Zhou, Caicun; Cai, Linbo; Su, Chunxia; Zhou, Zhaoming; Wen, Lei